Cancer Medicine

Top Research Topics at Cancer Medicine?

The scientific interests tackled in Cancer Medicine are Internal medicine, Oncology, Cancer, Cancer research and Gastroenterology. Internal medicine studies presented in it focus on topics such as Proportional hazards model, Chemotherapy, Hazard ratio, Cohort and Breast cancer. Hazard ratio studies tackled cover an aspect of the field of Confidence interval.

The research on Oncology tackled can also make contributions to studies in the areas of Stage (cooking), Survival analysis, Colorectal cancer and Radiation therapy. While Cancer is the focus of the journal, it also provided insights into the studies of Epidemiology, Incidence (epidemiology), Retrospective cohort study and Disease. The concepts on Cancer research presented in Cancer Medicine can also apply to other research fields, including Cell growth, Apoptosis, Gene knockdown, Carcinogenesis and Metastasis.

• Internal medicine (50.42%)
• Oncology (28.33%)
• Cancer (24.22%)

What are the most cited papers published in the journal?

• PD-1 as a potential target in cancer therapy (319 citations)
• Ipilimumab and radiation therapy for melanoma brain metastases (207 citations)
• β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties (198 citations)

Research areas of the most cited articles at Cancer Medicine:

The journal papers are organized to reinforce research efforts on Internal medicine, Cancer research, Cancer, Oncology and Pathology. The journal papers facilitate discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology and Surgery. The journal publications focus on Oncology but the discussions also offer insight into other areas such as Stage (cooking), Melanoma, Proportional hazards model and Hazard ratio.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Gene

The previous edition focused in particular on these issues:

The journal explores disciplines such as Internal medicine, Oncology, Cancer, Cancer research and Proportional hazards model. It focuses on Internal medicine research which is adjacent to topics in Gastroenterology. Cancer Medicine addresses concerns in Oncology which are intertwined with other disciplines, such as Stage (cooking), Breast cancer and Receiver operating characteristic.

Topics in Cancer explored in the journal were investigated in conjunction with research in Epidemiology, Cohort study, Disease and Incidence (epidemiology). In Cancer Medicine, Carcinogenesis, Tumor progression, Gene, Immune system and Metastasis are investigated in conjunction with one another to address concerns in Cancer research research. The journal explores studies in Hazard ratio as part of the wider topic of Confidence interval.

The most cited articles from the last journal are:

• Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe). (13 citations)
• Enhancement of tumor lethality of ROS in photodynamic therapy. (9 citations)
• A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer (9 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Cancer Medicine (based on the number of publications) are:

• Zhibin Hu (13 papers) absent at the last edition,
• Yoshihiko Maehara (11 papers) published 1 paper at the last edition,
• Yoshinao Oda (11 papers) published 3 papers at the last edition,
• Jie He (11 papers) published 4 papers at the last edition, 1 more than at the previous edition,
• Kelvin K. W. Chan (11 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Medicine (based on the number of publications) are:

• Sun Yat-sen University (167 papers) published 29 papers at the last edition, 16 less than at the previous edition,
• Fudan University (162 papers) published 13 papers at the last edition, 39 less than at the previous edition,
• Nanjing Medical University (113 papers) published 18 papers at the last edition, 14 less than at the previous edition,
• Peking Union Medical College (109 papers) published 29 papers at the last edition, 4 less than at the previous edition,
• University of Texas MD Anderson Cancer Center (103 papers) published 23 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.70% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.23% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.81% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.09% of all publications and 45.87% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

How to Become a Cancer Researcher

For those interested in the comprehensive study and treatment of cancer, a career as a cancer researcher could be fulfilling and rewarding. The first step to becoming a cancer researcher is typically acquiring a bachelor's degree in a life science field such as biology or biochemistry, after which most individuals choose to pursue graduate studies. Graduate studies usually involve obtaining a doctorate, usually a Ph.D., in a field such as molecular biology or genetics. During this time, students will conduct deep research in their chosen field, contributing knowledge to the academic community and gaining valuable laboratory skills. After completing their doctorate, aspiring cancer researchers move on to postdoctoral studies. This stage enables scholars to specialize in cancer research and gain further laboratory research experience under the guidance of experienced researchers. Finally, individuals may consider pursuing medical licensure to bolster their abilities to conduct intensive clinical research. The requirements for obtaining a medical license vary by state. For example, if you're looking to meet Minnesota nursing license requirements, you would need to complete an approved nursing education program and pass the National Council Licensure Examination (NCLEX-RN). Once all education and licensure steps have been completed, successful cancer researchers will continually develop their knowledge and skills by staying abreast of the latest advancements and discoveries in the field of cancer research. It is a highly dynamic and inevitably demanding career that promises significant contributions to the fight against cancer and groundbreaking innovations in cancer medicine.